Lupin Q1 FY27 Results Date: Key Timings, Revenue Range 2026

What investors are tracking this week

Lupin Ltd is set to report its first-quarter FY27 numbers, with the board scheduled to meet on Thursday, August 6, 2026, to review and approve the financial results for the quarter ended June 30, 2026. The company is expected to take up both unaudited standalone and consolidated results at the meeting. While the outcome is a routine regulatory event, the update matters because it sets the tone for FY27 after a strong prior-year base. Market expectations cited for the quarter point to consolidated revenue in a wide band of ₹6,300 crore to ₹7,096 crore. The company is also expected to discuss performance and outlook in a planned earnings conference call the following day.

Board meeting fixed for August 6, 2026

Lupin’s board meeting is scheduled for August 6, 2026, and the results are expected to be disclosed during or following the meeting. The company is expected to file the outcome with the BSE and NSE after the board’s review. An exact clock time for the release of Lupin’s Q1 results has not been officially specified in advance. That means investors typically track exchange filings through the day for the result document. The quarter under review is April to June 2026, which corresponds to Q1 FY27.

Earnings call on August 7 at 4:30 PM IST

Lupin has scheduled its earnings conference call for Friday, August 7, 2026, at 4:30 PM IST. The call is expected to include management commentary on Q1 performance and the near-term outlook. For market participants, this call often provides additional context that is not visible in headline numbers, including region-level trends and operational updates. With the results timing not fixed to a specific hour on August 6, the call timing gives investors a clear point to listen for management direction after the numbers are out.

Trading window closure: July 1 to August 9, 2026

In line with insider trading regulations, Lupin’s trading window for designated persons has been closed from Wednesday, July 1, 2026. The window is scheduled to reopen on Sunday, August 9, 2026, which is stated as 48 hours after the results declaration. Trading window closures are standard practice around earnings, and they signal the formal earnings calendar to the market. For investors, the key takeaway is that the company has placed the August 6 meeting at the centre of its quarter-end compliance timeline.

Street revenue expectations for Q1 FY27

Expectations cited for Lupin’s Q1 FY27 results indicate consolidated revenue in the range of ₹6,300 crore to ₹7,096 crore. The span is broad, suggesting that estimates could vary on assumptions around key markets and product mix. No profit or margin expectation range is provided in the available details, so revenue becomes the primary numerical reference point ahead of the release.

How Q1 FY26 sets the benchmark

The upcoming Q1 FY27 numbers will be compared with a strong year-ago quarter. For Q1 FY26 (quarter ended June 30, 2025), Lupin reported a year-on-year rise of about 52% in consolidated profit after tax, with PAT reported at about ₹1,221 crore. In the same quarter, consolidated sales or revenue from operations were reported at ₹6,164 crore, compared with ₹5,514 crore in the year-ago period, as per the company’s statement.

Separately, a quarterly table for the quarter ended June 2025 lists total revenue at ₹6,268.34 crore and net income at ₹1,219.03 crore, along with operating income of ₹1,342.39 crore. These figures are also presented alongside quarter-on-quarter comparisons versus the March 2026 quarter and year-on-year comparisons versus June 2024. Taken together, the disclosed data highlights that the prior-year base was elevated on both revenue growth and profit expansion.

US and India performance: what was highlighted last year

For Q1 FY26, Lupin disclosed that US sales were ₹2,404 crore in the June quarter, up from ₹1,934 crore a year earlier. India sales for Q1 FY26 were ₹2,089 crore, up from ₹1,938 crore in the year-ago period. A consolidated results snapshot also lists US sales at ₹2,404.1 crore (INR 24,041 million) and India sales at ₹2,089.4 crore (INR 20,894 million) for Q1 FY26.

Profitability indicators reported for Q1 FY26 included EBITDA of ₹1,806.3 crore (INR 18,063 million) and an EBITDA margin of 29.3%. The company also disclosed gross profit of ₹4,391.9 crore (INR 43,919 million) and an R&D investment of ₹484.4 crore (INR 4,844 million), stated as 7.9% of sales.

Milestone income that supported profitability in Q1 FY26

Lupin attributed part of the June-quarter profit strength to income received from Boehringer Ingelheim for achieving key milestones under a novel MEK inhibitor compound collaboration. The company stated that gross profit was supported by USD 50 million, described as over ₹370 crore, received for the milestone achievement. This factor is relevant context for year-on-year comparisons because it may influence how investors interpret the sustainability of profit growth versus core operating performance.

Key dates and numbers at a glance

Market impact: what to watch as the filing hits exchanges

With the exact release time not specified, the immediate market reaction is typically tied to when the exchange filing appears and how the reported revenue compares with the stated expectation band of ₹6,300 crore to ₹7,096 crore. Investors may also compare Q1 FY27 prints with the strong Q1 FY26 base that included PAT of about ₹1,221 crore and revenue from operations of ₹6,164 crore. The scheduled earnings call on August 7 at 4:30 PM IST is likely to be the next catalyst for incremental information, especially any colour on the US and India segments that were highlighted previously.

Why this event matters for FY27 tracking

The August 6 board meeting is the formal trigger for Lupin’s Q1 FY27 disclosure and the start of the market’s FY27 scorecard. Last year’s quarter included strong profitability and also referenced milestone income from a collaboration, which adds context for comparability. With revenue expectations set out in a wide range, the actual reported number and management’s narrative on the earnings call are likely to shape how investors frame the first quarter.

Conclusion

Lupin’s Q1 FY27 results are scheduled for consideration on August 6, 2026, with the earnings call set for August 7 at 4:30 PM IST. The key pre-result reference point is the consolidated revenue expectation of ₹6,300 crore to ₹7,096 crore, against a Q1 FY26 revenue from operations figure of ₹6,164 crore. Investors will look for the exchange filing once it is released and then for management commentary in the scheduled call.